Free Trial

Purple Biotech (PPBT) Competitors

Purple Biotech logo
$0.58 +0.01 (+1.30%)
Closing price 03:53 PM Eastern
Extended Trading
$0.58 +0.00 (+0.34%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PPBT vs. RNTX, SONN, DARE, ENLV, CVKD, PASG, LPTX, PMN, LNAI, and CASI

Should you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include Rein Therapeutics (RNTX), Sonnet BioTherapeutics (SONN), Dare Bioscience (DARE), Enlivex Therapeutics (ENLV), Cadrenal Therapeutics (CVKD), Passage Bio (PASG), Leap Therapeutics (LPTX), Promis Neurosciences (PMN), Lunai Bioworks (LNAI), and CASI Pharmaceuticals (CASI). These companies are all part of the "pharmaceutical products" industry.

Purple Biotech vs. Its Competitors

Rein Therapeutics (NASDAQ:RNTX) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

90.9% of Rein Therapeutics shares are held by institutional investors. Comparatively, 9.6% of Purple Biotech shares are held by institutional investors. 5.1% of Rein Therapeutics shares are held by company insiders. Comparatively, 3.0% of Purple Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Purple Biotech is trading at a lower price-to-earnings ratio than Rein Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rein TherapeuticsN/AN/A-$62.88M-$2.69-0.45
Purple BiotechN/AN/A-$7.24M-$0.42-1.39

In the previous week, Purple Biotech had 3 more articles in the media than Rein Therapeutics. MarketBeat recorded 3 mentions for Purple Biotech and 0 mentions for Rein Therapeutics. Purple Biotech's average media sentiment score of 0.33 beat Rein Therapeutics' score of 0.00 indicating that Purple Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Rein Therapeutics Neutral
Purple Biotech Neutral

Rein Therapeutics has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Rein Therapeutics currently has a consensus target price of $10.00, suggesting a potential upside of 719.67%. Purple Biotech has a consensus target price of $33.00, suggesting a potential upside of 5,560.38%. Given Purple Biotech's higher possible upside, analysts plainly believe Purple Biotech is more favorable than Rein Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rein Therapeutics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Purple Biotech
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Purple Biotech's return on equity of -14.00% beat Rein Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Rein TherapeuticsN/A -141.11% -33.83%
Purple Biotech N/A -14.00%-12.52%

Summary

Purple Biotech beats Rein Therapeutics on 7 of the 11 factors compared between the two stocks.

Get Purple Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PPBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PPBT vs. The Competition

MetricPurple BiotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.49M$3.40B$6.21B$10.54B
Dividend YieldN/A2.27%5.74%4.88%
P/E Ratio-1.3923.0629.1327.15
Price / SalesN/A436.69553.81164.89
Price / CashN/A46.4037.3861.65
Price / Book0.0510.4512.306.46
Net Income-$7.24M-$52.53M$3.33B$276.63M
7 Day Performance-9.22%-1.46%-1.46%-2.60%
1 Month Performance2.77%9.70%5.03%0.33%
1 Year Performance-87.04%11.69%61.45%30.66%

Purple Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PPBT
Purple Biotech
2.3183 of 5 stars
$0.58
+1.3%
$33.00
+5,560.4%
-87.2%$7.49MN/A-1.3920News Coverage
RNTX
Rein Therapeutics
2.6232 of 5 stars
$1.32
+1.5%
$10.00
+657.6%
N/A$30.30MN/A-0.499
SONN
Sonnet BioTherapeutics
1.7068 of 5 stars
$4.37
-0.9%
$20.00
+357.7%
-31.9%$30.11M$20K0.0010Gap Down
DARE
Dare Bioscience
1.8225 of 5 stars
$2.12
flat
$10.00
+371.7%
-41.5%$28.58M$10K-0.9930Positive News
ENLV
Enlivex Therapeutics
2.5237 of 5 stars
$1.10
-4.3%
$10.00
+809.1%
-28.4%$27.94MN/A-1.9070Gap Down
CVKD
Cadrenal Therapeutics
2.8963 of 5 stars
$13.99
+2.7%
$32.00
+128.7%
-13.4%$27.88MN/A-1.584Gap Up
PASG
Passage Bio
3.0982 of 5 stars
$8.69
+2.6%
$75.67
+770.7%
-26.2%$26.93MN/A-0.48130News Coverage
Gap Down
LPTX
Leap Therapeutics
2.7749 of 5 stars
$0.60
-5.5%
$3.38
+459.6%
-83.7%$26.46MN/A-0.3840Short Interest ↓
PMN
Promis Neurosciences
3.7442 of 5 stars
$0.48
-2.0%
$4.33
+802.8%
-53.7%$26.37MN/A-2.295News Coverage
Positive News
Short Interest ↓
LNAI
Lunai Bioworks
N/A$1.16
+2.7%
N/AN/A$26.19MN/A-0.1520Gap Down
CASI
CASI Pharmaceuticals
3.5814 of 5 stars
$1.89
-4.5%
$4.00
+111.6%
-68.4%$24.35M$28.54M-0.65180

Related Companies and Tools


This page (NASDAQ:PPBT) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners